Publication | Open Access

Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse

Chronic PhaseChromatinHematological MalignancyMedicineMixed-phenotype Acute LeukemiaHematologyMyeloid NeoplasiaPathologyResidual LeukaemiaComplete Cytogenetic RemissionOncologyRadiation OncologyCancer ResearchHealth Sciences